At the launch of the latest malaria guidelines, January 2006, the WHO called on pharmaceutical companies to immediately stop marketing single-drug artemisinin tablets and only market artemisinin combination therapies instead, to prevent malaria parasites from developing resistance to this drug
www.who.int
Artemisinin could become a whole lot cheaper as researchers, led by Jay Keasling (and sponsored by IOWH and Gates Foundation), were able to readily convert artemisinic acid (AA) out of yeast. This could have positive impact on lowering the cost of artemisinin combination therapies for malaria.
www.nature.com